Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy

Authors: Xiaofei Xin, Virender Kumar, Feng Lin, Vinod Kumar, Rajan Bhattarai, Vijaya R. Bhatt, Chalet Tan, Ram I. Mahato

Published: 2020-11-12

DOI: 10.1126/sciadv.abd6764

Source: Full article

---

Abstract

Redox-responsive nanomedicine of miR-519c and gemcitabine effectively inhibits pancreatic tumor growth in mice.